Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer

Stopped Recruitment difficulties, decline in the incidence of the studied pathology, active competitive clinical trials

Conditions

• Small Cell Lung Cancer
• Platinum-Sensitive Lung Small Cell Carcinoma
• Extensive-stage Small-cell Lung Cancer

Interventions

• DRUG: Association of lurbinectedin and durvalumab
• DRUG: Association of carboplatin and etoposide

Sponsor

Institut Bergonié

Collaborators

• [object Object]
• [object Object]